Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/565
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNartey, Edmund T.-
dc.contributor.authorTetteh, Raymond A.-
dc.contributor.authorYankey, Barbara A.-
dc.contributor.authorMantel‑Teeuwisse, Aukje K.-
dc.contributor.authorLeufkens, Hubert G. M.-
dc.contributor.authorDodoo, Alexander N. O.-
dc.contributor.authorLartey, Margaret-
dc.date.accessioned2024-05-03T10:05:23Z-
dc.date.available2024-05-03T10:05:23Z-
dc.date.issued2019-
dc.identifier.citationNartey, E. T., Tetteh, R. A., Yankey, B. A., Mantel-Teeuwisse, A. K., Leufkens, H. G., Dodoo, A. N., & Lartey, M. (2019). Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana. BMC research notes, 12, 1-6.en_US
dc.identifier.urihttps://doi.org/10.1186/s13104-019-4454-2-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/565-
dc.description.abstractObjective: Tenofovir disoproxil fumarate (TDF) is a nucleotide analogue recommended in international HIV treat‑ ment guidelines. Purpose of this study was to estimate the long term efects of TDF on renal profle in a cohort of HIV patients in Ghana. Three hundred (300) consecutive HIV-positive patients who initiated TDF-based antiretroviral treat‑ ment in 2008 at the Korle-Bu Teaching Hospital were sampled. Creatinine clearance (CrCl) was calculated using the Cockcroft-Gault equation at baseline and renal impairment was defned as CrCl values of 30.0–49.9 mL/min (moder‑ ate renal impairment) and<30 mL/min (severe renal impairment) as per institutional guidelines for renal function test. Results: Median follow up time was 2.9 years (IQR 2.3–3.4 years). At study endpoint, 63 participants (21.0% [95% CI 6.5–26.1]) recorded CrCl rate below 50 mL/min indicating incident renal impairment, made up of 18.3% moderate renal impairment and 2.3% severe renal impairment. Factors associated with incidence of renal impairment were increasing age, decrease in creatinine clearance rate at baseline, WHO HIV stage III/IV and participants with BMI of<18.5 kg/m2 . Patients with identifed renal impairment risk factors at ART initiation should be targeted and moni‑ tored efectively to prevent renal injury.en_US
dc.description.sponsorshipThe project was financed personally by the authors.en_US
dc.language.isoenen_US
dc.publisherBMC research notesen_US
dc.subjectTenofovir disoproxil fumarateen_US
dc.subjectRenal dysfunctionen_US
dc.subjectCreatinine clearanceen_US
dc.subjectHIVen_US
dc.subjectARTen_US
dc.titleTenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghanaen_US
dc.typeArticleen_US
Appears in Collections:ARTICLES

Files in This Item:
File Description SizeFormat 
Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana.pdf739.08 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.